Montefiore Einstein Comprehensive Cancer Center (MECCC) Director Edward "Ed" Chu, MD, MMS, died on November 13 of glioblastoma. A dedicated member of the AACI Board of Directors, Dr. Chu was committed to providing compassionate care to patients and advancing research to improve treatments for colorectal and GI cancers.
He had a distinguished career as a physician-scientist, holding tenured positions and leadership roles at Yale School of Medicine and Yale Cancer Center, and University of Pittsburgh School of Medicine, where he was chief of hematology-oncology and deputy director of the UPMC Hillman Cancer Center. Dr. Chu joined MECCC in the fall of 2020. During his tenure, he transformed the cancer center into a fully integrated, unified cancer enterprise, resulting in its first comprehensive designation from the National Cancer Institute. In addition to his role as director of MECCC, Dr. Chu was vice president of cancer medicine and the Carol and Roger Einiger Professor of Cancer Medicine, and he acted as interim chair of the department of oncology until 2024.
Beyond Dr. Chu’s professional leadership, he will be remembered for his warmth and compassion. He served as a trusted advisor and mentor for numerous students, fellows, faculty colleagues, and leaders of NCI-Designated Cancer Centers. MECCC has established the Edward Chu Fund for Cancer Research in his memory.
The Cancer Letter: Montefiore Einstein Director Edward Chu Dies of Glioblastoma at 66
Albert Einstein College of Medicine: Remembering Dr. Edward Chu, Director of the Montefiore Einstein Comprehensive Cancer Center